These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 10384481)

  • 1. Modeling and simulation in molecular pharmacology.
    Mihalas GI; Kygyosi A; Lungeanu D; Vernic C
    Stud Health Technol Inform; 1998; 52 Pt 1():372-5. PubMed ID: 10384481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mechanism of receptor regulation during repeated administration of drugs].
    Montastruc JL; Galitzky J; Berlan M; Montastruc P
    Therapie; 1993; 48(5):421-6. PubMed ID: 8146818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A model of TLR4 signaling and tolerance using a qualitative, particle-event-based method: introduction of spatially configured stochastic reaction chambers (SCSRC).
    An G
    Math Biosci; 2009 Jan; 217(1):43-52. PubMed ID: 18950646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Data for the modeling of drug-receptor interaction, taking into consideration additives or combined active ingredients in the formulation].
    Bozzay J; Békefi E; Dávid A; Rusznák I
    Acta Pharm Hung; 1983 May; 53(3):97-105. PubMed ID: 6880768
    [No Abstract]   [Full Text] [Related]  

  • 5. [Receptor occupation theory and its parameter estimates (author's transl)].
    Xu DZ
    Sheng Li Ke Xue Jin Zhan; 1981 Oct; 12(4):318-24. PubMed ID: 7344074
    [No Abstract]   [Full Text] [Related]  

  • 6. [Drugs: molecular pharmacology, sites of action and drug receptors].
    Astier A
    Soins; 1984 Oct; (439):13-25. PubMed ID: 6569695
    [No Abstract]   [Full Text] [Related]  

  • 7. On nonoscillation and monotonicity of solutions of nonnegative and compartmental dynamical systems.
    Chellaboina V; Haddad WM; Bailey JM; Ramakrishnan J
    IEEE Trans Biomed Eng; 2004 Mar; 51(3):408-14. PubMed ID: 15000372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A SAS macro for target dose estimation by reinforced urn processes in phase I clinical trials.
    Zhong C; Zhuo Y; Xia J; Hu S; Li C; Jiang Z; Wang S
    Comput Methods Programs Biomed; 2011 Mar; 101(3):282-96. PubMed ID: 21329999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computer simulations of bioequivalence trials: selection of design and analyte in BCS drugs with first-pass hepatic metabolism: linear kinetics (I).
    Fernández-Teruel C; Nalda Molina R; González-Alvarez I; Navarro-Fontestad C; García-Arieta A; Casabó VG; Bermejo M
    Eur J Pharm Sci; 2009 Jan; 36(1):137-46. PubMed ID: 19028574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of the relation between pharmacokinetic processes and pharmacological effects in humans].
    Dorokhov VV; Kholodov LE
    Farmakol Toksikol; 1985; 48(5):119-25. PubMed ID: 3908140
    [No Abstract]   [Full Text] [Related]  

  • 11. [Model building in pharmacokinetics/Part V: Simulation of blood level curves following repetitive dosing and their experimental verification (author's transl)].
    Hammer R; Bozler G; Heinzel G; Koss FW
    Arzneimittelforschung; 1977; 27(4a):928-31. PubMed ID: 577860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular automata model for swelling-controlled drug release.
    Laaksonen H; Hirvonen J; Laaksonen T
    Int J Pharm; 2009 Oct; 380(1-2):25-32. PubMed ID: 19563871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Robustness of choice of number of doses for maximum likelihood estimation of the ED(50) in bioassay.
    Huang Y
    Stat Med; 2002 Aug; 21(15):2215-23. PubMed ID: 12210634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mathematical modeling of drug delivery from torus-shaped single-layer devices.
    Helbling IM; Luna JA; Cabrera MI
    J Control Release; 2011 Feb; 149(3):258-63. PubMed ID: 20971140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The need for modeling and simulation to design clinical investigations in children.
    Jadhav PR; Kern SE
    J Clin Pharmacol; 2010 Sep; 50(9 Suppl):121S-129S. PubMed ID: 20881225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue density of drugs with respect to time.
    Booth NH
    J Am Vet Med Assoc; 1980 May; 176(10 Spec No):1134-40. PubMed ID: 7216888
    [No Abstract]   [Full Text] [Related]  

  • 17. The classification of drugs and drug receptors in isolated tissues.
    Kenakin TP
    Pharmacol Rev; 1984 Sep; 36(3):165-222. PubMed ID: 6093156
    [No Abstract]   [Full Text] [Related]  

  • 18. [Social equivalents of the biological protective-adaptive mechanisms of animals and pharmacology].
    Zheliazkov D
    Eksp Med Morfol; 1984; 23(1):1-8. PubMed ID: 6432514
    [No Abstract]   [Full Text] [Related]  

  • 19. Pseudoreceptor models in drug design: bridging ligand- and receptor-based virtual screening.
    Tanrikulu Y; Schneider G
    Nat Rev Drug Discov; 2008 Aug; 7(8):667-77. PubMed ID: 18636071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A microcomputer program for the analysis of the drug-receptor bond using radioligands].
    García AJ; Ríus F; López DR; Martos F; de la Cruz JP; Gómez JA; Sánchez de la Cuesta F
    Arch Farmacol Toxicol; 1986 Apr; 12(1):71-82. PubMed ID: 3755582
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.